However, despite these findings suggesting a key role of autophagy in the etiology of MM and the existence of a genetic component controlling this catalytic process in MM, so far only ULK4, ATG5, and CDKN2A polymorphisms have been suggested to have an impact on the risk of MM [38,39]. This evidence concerns the gene CDKN2A and Miyoshi myopathy.